ophthalmologytimes55m
Updates you may have missed: Clinical trials, funding, and shelved projects
Catch up on the clinical trial news, updates from the United States Food and Drug Administration (FDA), and company funding ...
ophthalmologytimes55m
Acelyrin unveils phase 3 program design for lonigutamab in thyroid eye disease
The company also released additional data from its phase 2 clinical trial in addition to the LONGITUDE program design.